ImmusanT is a clinical development-stage biotechnology company focused on an innovative disease-modifying approach to induce immune tolerance in autoimmune diseases.
Diasome Pharmaceuticals, Inc. is focused on the clinical and commercial development of breakthrough therapies for diabetes and obesity.
Bigfoot Biomedical is a medical device company developing technologies to reduce the cognitive, emotional, and financial burden of insulin-requiring diabetes.
The SQZ Biotech CellSqueeze enables the delivery of molecules into cells by a gentle squeezing. That's right, we squeeze cells.
Inversago Pharma is a specialized, preclinical-stage biotech company.
Semma Therapeutics was founded to develop transformative therapies for Type 1 diabetes patients.
Provention Bio is a clinical-stage biopharmaceutical company dedicated to sourcing, developing and commercializing novel therapeutics and cutting-edge solutions to intercept and prevent immune-mediated disease.